Skip to Main content Skip to Navigation
Journal articles

Dominant immune response to HLA‐B57/B58 molecules after platelet transfusion

Abstract : Background: Patients with hematologic malignancies require prophylactic or curative platelet transfusions to prevent or treat bleeding. Treatments such as chemotherapy, radiotherapy, and hematopoietic stem cell transplantation cause persistent thrombocytopenia, necessitating platelet transfusions. However, class I HLA antibodies can cause a serious complication: immune-mediated platelet refractoriness. The mechanisms of alloimmunization are incompletely understood. We explored the immunogenicity of HLA molecules and the phenotype of the HLA-specific CD4+ T cells involved in alloimmunization. Study design and methods: We investigated the role of HLA molecules in platelet transfusion immunogenicity in a retrospective cohort study on men with specific anti-HLA who had undergone transfusion. We investigated the presence and phenotypic profile of HLA-specific CD4+ T cells in alloimmunized patients included in long-term platelet transfusion programs for hematologic malignancies. Results: More than 50% of the transfused subjects displayed an antibody response against HLA-B57 or -B58. HLA-B57-specific CD4+ T-cell responses were observed in patients alloimmunized against HLA-B57. Following specific stimulation, the patients presented HLA-specific CD4+ T cells producing tumor necrosis factor-α, interleukin (IL)-13, IL-17A, IL-2, IL-10, and IL-21. Conclusion: These results shed light on posttransfusion class I anti-HLA alloimmunization mechanisms and constitute a first step toward developing new strategies for reducing refractoriness.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-03129762
Contributor : Benoit Vingert Connect in order to contact the contributor
Submitted on : Wednesday, February 3, 2021 - 9:34:36 AM
Last modification on : Wednesday, November 3, 2021 - 6:48:27 AM
Long-term archiving on: : Tuesday, May 4, 2021 - 6:21:31 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Justine Coombs, Latifa Ben Hassen, Mathieu Leclerc, Marie Tamagne, Louise Pannetier, et al.. Dominant immune response to HLA‐B57/B58 molecules after platelet transfusion. Transfusion, Wiley, 2020, 60, pp.2807 - 2814. ⟨10.1111/trf.16116⟩. ⟨inserm-03129762⟩

Share

Metrics

Record views

25